Zevra Therapeutics (ZVRA) Non-Current Deferred Tax Liability (2018 - 2020)
Historic Non-Current Deferred Tax Liability for Zevra Therapeutics (ZVRA) over the last 5 years, with Q4 2020 value amounting to $476000.0.
- Zevra Therapeutics' Non-Current Deferred Tax Liability fell 1185.19% to $476000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $476000.0, marking a year-over-year decrease of 1185.19%. This contributed to the annual value of $476000.0 for FY2020, which is 1185.19% down from last year.
- Zevra Therapeutics' Non-Current Deferred Tax Liability amounted to $476000.0 in Q4 2020, which was down 1185.19% from $540000.0 recorded in Q4 2019.
- Over the past 5 years, Zevra Therapeutics' Non-Current Deferred Tax Liability peaked at $540000.0 during Q4 2019, and registered a low of $171000.0 during Q4 2018.
- For the 3-year period, Zevra Therapeutics' Non-Current Deferred Tax Liability averaged around $395666.7, with its median value being $476000.0 (2020).
- Per our database at Business Quant, Zevra Therapeutics' Non-Current Deferred Tax Liability soared by 21578.95% in 2019 and then tumbled by 1185.19% in 2020.
- Zevra Therapeutics' Non-Current Deferred Tax Liability (Quarter) stood at $171000.0 in 2018, then soared by 215.79% to $540000.0 in 2019, then decreased by 11.85% to $476000.0 in 2020.
- Its Non-Current Deferred Tax Liability stands at $476000.0 for Q4 2020, versus $540000.0 for Q4 2019 and $171000.0 for Q4 2018.